You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 14, 2025

Drug Price Trends for GNP COLD HEAD CONGST SEVR CPLT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP COLD HEAD CONGST SEVR CPLT

Average Pharmacy Cost for GNP COLD HEAD CONGST SEVR CPLT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP COLD HEAD CONGST SEVR CPLT 46122-0415-62 0.11597 EACH 2024-12-18
GNP COLD HEAD CONGST SEVR CPLT 46122-0415-62 0.11453 EACH 2024-11-20
GNP COLD HEAD CONGST SEVR CPLT 46122-0415-62 0.11741 EACH 2024-10-23
GNP COLD HEAD CONGST SEVR CPLT 46122-0415-62 0.11283 EACH 2024-09-18
GNP COLD HEAD CONGST SEVR CPLT 46122-0415-62 0.10857 EACH 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for GNP COLD+HEAD CONGESTION SEVERE CAPLETS

Market Overview

The market for over-the-counter (OTC) cold and flu medications is highly competitive and influenced by various factors, including regulatory changes, consumer preferences, and the availability of alternative treatments.

Regulatory Environment

Recent regulatory actions, such as the FDA's proposed order to remove oral phenylephrine from the OTC monograph, can significantly impact the market dynamics of cold and flu medications. This proposal, although not related to safety, could lead to reformulations or changes in product offerings, affecting consumer choices and market shares[2].

Consumer Demand

The demand for cold and flu medications remains steady, driven by the common occurrence of respiratory infections. Products like GNP COLD+HEAD CONGESTION SEVERE CAPLETS, which offer relief from multiple symptoms such as minor aches and pains, headaches, sore throat, nasal congestion, and sinus congestion, are in constant demand.

Product Details and Competitiveness

Active Ingredients

GNP COLD+HEAD CONGESTION SEVERE CAPLETS typically contain active ingredients like acetaminophen (pain reliever/fever reducer), guaifenesin (expectorant), and phenylephrine (nasal decongestant). These ingredients are common in many cold and flu medications, making the product competitive in the market[2].

Competitive Landscape

The market is dominated by well-known brands such as Tylenol, which offers similar products like Tylenol Cold + Head Congestion Severe Caplets. These brands often have strong marketing and distribution networks, making it challenging for generic or store-brand products to gain significant market share. However, generic products like GNP COLD+HEAD CONGESTION SEVERE CAPLETS can attract price-conscious consumers[2].

Pricing and Cost Considerations

Current Pricing

As of the current market, GNP COLD+HEAD CONGESTION SEVERE CAPLETS are priced competitively, often lower than brand-name alternatives. For example, they are available for $6.99 for a 24-count package, making them an attractive option for budget-conscious consumers[5].

Price Projections

Given the overall trend in pharmaceutical pricing, it is expected that drug prices will continue to rise, albeit at a moderate rate. Vizient, Inc. projects a 3.81% overall drug price inflation rate for 2025, which could influence the pricing of OTC medications as well. However, generic and store-brand products are likely to remain more stable in terms of pricing due to their lower cost structure[3].

Consumer Safety and Regulatory Compliance

Safety Concerns

The use of cold and flu medications, especially in children, has been a subject of regulatory scrutiny. The FDA has issued warnings and guidelines to ensure safe use, particularly for ingredients like phenylephrine and pseudoephedrine. Manufacturers must comply with these regulations to avoid any adverse events and maintain consumer trust[1][4].

Labeling and Warnings

Products like GNP COLD+HEAD CONGESTION SEVERE CAPLETS must include detailed labeling and warnings to inform consumers about potential side effects, such as liver damage from acetaminophen, and contraindications, such as use in children under certain ages or in patients with specific health conditions[2].

Pharmacological Effects and Efficacy

Active Ingredients and Their Effects

  • Phenylephrine: Acts as a nasal decongestant by causing vasoconstriction, reducing blood flow to the nose and sinusoid vessels, thereby relieving nasal congestion[1][4].
  • Guaifenesin: Loosens and thins sputum and bronchial secretions, making coughs more productive[2].
  • Acetaminophen: Provides relief from minor aches and pains, headaches, and reduces fever[2].

Efficacy and Consumer Satisfaction

The efficacy of these ingredients in providing temporary relief from cold and flu symptoms is well-documented. Consumer satisfaction is high for products that effectively alleviate multiple symptoms, making them a preferred choice during cold and flu seasons.

Special Populations and Usage Guidelines

Pediatric Use

The FDA has strict guidelines against the use of OTC cough and cold medications in children under 2 years of age due to the risk of serious adverse events. For children between 2 to 5 years, caution is advised, and products should be used only under the guidance of a healthcare professional[1][4].

Geriatric and Other Special Populations

For older adults or individuals with chronic conditions like heart disease, high blood pressure, or diabetes, it is crucial to consult a healthcare provider before using these medications. This ensures safe use and avoids potential interactions with other medications[2].

Key Takeaways

  • Regulatory Changes: Ongoing regulatory changes, such as the proposed removal of phenylephrine from OTC monographs, can impact product formulations and market dynamics.
  • Consumer Demand: Steady demand for cold and flu medications driven by common respiratory infections.
  • Pricing: Competitive pricing with a projected moderate increase due to overall drug price inflation.
  • Safety and Compliance: Strict adherence to FDA guidelines and warnings to ensure safe use, especially in children and special populations.
  • Efficacy: Effective relief from multiple cold and flu symptoms through active ingredients like phenylephrine, guaifenesin, and acetaminophen.

Frequently Asked Questions (FAQs)

Q: What are the active ingredients in GNP COLD+HEAD CONGESTION SEVERE CAPLETS? A: The active ingredients include acetaminophen, guaifenesin, and phenylephrine.

Q: Can I use GNP COLD+HEAD CONGESTION SEVERE CAPLETS for children under 2 years old? A: No, the FDA advises against using OTC cough and cold medications in children under 2 years of age due to the risk of serious adverse events.

Q: How often can I take GNP COLD+HEAD CONGESTION SEVERE CAPLETS? A: You can take 2 caplets every 4 hours, but do not exceed 10 caplets in 24 hours.

Q: What are the potential side effects of using GNP COLD+HEAD CONGESTION SEVERE CAPLETS? A: Potential side effects include liver damage from acetaminophen, drowsiness, xerostomia, nausea, tachycardia, and CNS depression.

Q: Can I use GNP COLD+HEAD CONGESTION SEVERE CAPLETS if I have liver disease or heart disease? A: It is advised to consult a healthcare provider before using these medications if you have liver disease, heart disease, or any other chronic condition.

Cited Sources

  1. Cough and Cold Therapeutic Class Review (TCR) - Magellan Rx Management, May 2022.
  2. TYLENOL® Cold + Head Congestion Severe Caplets - Tylenol.com.
  3. Vizient projects drug price inflation at 3.81% - Vizient, Inc., July 30, 2024.
  4. Cough and Cold Therapeutic Class Review (TCR) - Magellan Rx Management, May 2021.
  5. GNP COLD+HEAD CONG SEV CPL 24CT - Laketown Pharmacy.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.